Skip to main content
Log in

Bisphosphonates for prevention of hip fractures effective but costly

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. the most common fracture associated with osteoporosis

References

  1. Bhat SB, et al. Economic and Outcomes Analysis of Bisphosphonate Use after Distal Radius Fracture for Prevention of Hip Fracture. Internet Document : 24 Mar 2015. Available from: URL: http://aaos2015.conferencespot.org.

  2. American Academy of Orthopaedic Surgeons. Routine bisphosphonate treatment for women over age 65 who sustain a wrist fracture could prevent nearly 95,000 hip fractures, but at a significant cost. Media Release : 24 Mar 2015. Available from: URL: http://www.aaos.org.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bisphosphonates for prevention of hip fractures effective but costly. PharmacoEcon Outcomes News 725, 7 (2015). https://doi.org/10.1007/s40274-015-2021-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2021-1

Navigation